Cargando…

Fulminant myocarditis in adults: a narrative review

Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe hemodynamic compromise secondary to acute myocardial inflammation, often presenting as profound cardiogenic shock, life-threatening ventricular arrhythmias and/or electrical storm. FM may be refractory to conventio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montero, Santiago, Abrams, Darryl, Ammirati, Enrico, Huang, Florent, Donker, Dirk W., Hekimian, Guillaume, García-García, Cosme, Bayes-Genis, Antoni, Combes, Alain, Schmidt, Matthieu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915421/ https://www.ncbi.nlm.nih.gov/pubmed/35317391 http://dx.doi.org/10.11909/j.issn.1671-5411.2022.02.006

Ejemplares similares

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shock
por: Montero, Santiago, et al.
Publicado: (2022)

New concepts in fulminant myocarditis and risk of cardiac mortality
por: Ammirati, Enrico, et al.
Publicado: (2017)

Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults
por: Barhoum, Petra, et al.
Publicado: (2022)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory support
por: Marquet, Yann, et al.
Publicado: (2023)

Fulminant versus non fulminant acute myocarditis: evolution of functional parameters evaluated with cardiac magnetic resonance
por: Pedrotti, Patrizia, et al.
Publicado: (2016)

Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Enterovirus fulminant myocarditis as cause of acute heart failure in a newborn
por: Annoni, Giuseppe, et al.
Publicado: (2022)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19 – Authors' reply
por: Schmidt, Matthieu, et al.
Publicado: (2020)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis: case report
Publicado: (2022)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Successful heart transplantation for COVID‐19‐associated post‐infectious fulminant myocarditis
por: Gaudriot, Baptiste, et al.
Publicado: (2021)

SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study
por: Gauchotte, Guillaume, et al.
Publicado: (2021)

Severe pulmonary embolism in COVID-19 patients: a call for increased awareness
por: Hékimian, Guillaume, et al.
Publicado: (2020)

FULMINANT MYOCARDITIS IN COVID-19 WITH RAPID RECOVERY OF SYSTOLIC FUNCTION
por: Calhoun, Avery, et al.
Publicado: (2021)

Mode-of-action of the PROPELLA concept in fulminant myocarditis
por: Spillmann, Frank, et al.
Publicado: (2019)

Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017)

Fulminant myocarditis with myositis of ocular and respiratory muscles
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Immune-mediated mechanism in coronavirus fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Azd-1222: Fulminant myocarditis: case report
Publicado: (2022)

Fulminant Bacterial Myocarditis Presenting as Myocardial Infarction
por: Trpkov, Cvetan, et al.
Publicado: (2020)

Clinical and electrocardiographic characteristics in patients with fulminant myocarditis
por: Itoh, Tomonori, et al.
Publicado: (2022)

Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis
por: Fruhwald, Friedrich, et al.
Publicado: (2017)

Non-STEMI vs. STEMI Cardiogenic Shock: Clinical Profile and Long-Term Outcomes
por: Martínez, María José, et al.
Publicado: (2022)

Recovery from mRNA COVID-19 vaccine-related myocarditis
por: Ammirati, Enrico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ndo3l09ejnfpgmanfpfdls98ie